Neuraxis Inc. (NYSE AMERICAN: NRXS)
$2.85
-0.1650 ( -5.48% ) 5.6K
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).
Market Data
Open
$2.85
Previous close
$3.01
Volume
5.6K
Market cap
$19.88M
Day range
$2.94 - $3.06
52 week range
$1.80 - $6.93
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 17 | Jan 31, 2024 |
4 | Insider transactions | 1 | Jan 23, 2024 |
8-k | 8K-related | 12 | Dec 19, 2023 |
3 | Insider transactions | 2 | Dec 13, 2023 |
10-q | Quarterly Reports | 94 | Nov 20, 2023 |
nt | Quarterly Reports | 1 | Nov 14, 2023 |
8-k | 8K-related | 15 | Nov 14, 2023 |
10-q | Quarterly Reports | 88 | Sep 22, 2023 |
8-k | 8K-related | 45 | Sep 21, 2023 |
3 | Insider transactions | 1 | Sep 13, 2023 |